abstract |
The present invention provides a chimeric antigen receptor construct and a nucleic acid molecule of a humanized RP215 monoclonal antibody, the construct has the nucleotide sequence shown in Sequence Table 7, the nucleic acid comprises the construct, and can be applied It has important application value for tumor therapy. |